In summary, amygdalin is a candidate compound for COVID-19 treatment by regulating IL6, SRC, MAPK1, EGFR and VEGFA by way of the PI3K-Akt signalling pathway, VEGF signalling pathway and MAPK signalling pathway. The gene discussed is EGFR; the disease is COVID-19.